General: Commercially available reagents and anhydrous solvents were used without further purification unless otherwise specified. The final purity of all compounds was determined by analytical HPLC with an Agilent ZORBAX SB-C 18 column (2.1 mm x 150 mm). Analytical HPLC data were generated by injecting 20 μL of sample solution in methanol and acetonitrile to a reverse phase HPLC system run over 30 min (2-100% acetonitrile/water with 0.05%TFA and 2-100% methanol/water with 0.05% TFA). The products were detected by UV at the detection frequency of 254 nm. All compounds were determined to be >95% pure by this method. Flash chromatography was performed on prepacked columns of silica gel (Varian SF10-4g, Si 50) by IntelliFlash with EtOAc/hexanes or MeOH/CH 2 Cl 2 as eluent. The purification by preparative HPLC was performed on Varian Dynamax Microsorb 100-5 C 18 column (250 mm x 21.4 mm) with CH 3 CN/H 2 O or MeOH/H 2 O and 0.05% TFA as eluent. The mass spectra were recorded with the Bruker Esquire Liquid Chromatograph -Ion Trap Mass Spectrometer. NMR spectra were recorded with either a Bruker 300 MHz spectrometer or Bruker 500 MHz spectrometer at ambient temperature with the residual solvent peaks as internal standards. The chemical shifts are given in ppm (δ) and coupling constants are reported in Hz. 1 H resonances are referenced to CDCl 3 (7.26 ppm), DMSO-d 6 (2.54) or CD 3 OD (3.34).
The reaction was refluxed for 4 hours, then cooled to room temperature, at which point the product precipitated from solution.
The precipitate was filtered and the filtrate was collected and concentrated. The resulting residue was partitioned between equal volumes of EtOAc and saturated ammonium chloride. Separation of the organic phase, drying over Na 2 SO 4 , and concentration yielded indazole A. The crude product was taken on to the next step without further purification. 1 The following general procedure was used to synthesize final compounds 4-15:
3 equivalents of an acid and HOBt (21.7 mg, .157 mmol, 3 equiv.) were added to a solution of B (20 mg, 0.0523 mmol, 1 equiv) in DMF (1.0 mL). EDCI (26.5 mg, .157 mmol, 3 equiv.) was then added and the reaction mixture was stirred at room temperature overnight. The reaction mixture was then partitioned between EtOAc and saturated sodium carbonate, washed with ammonium chloride, brine, and dried over Na 2 SO 4 . The organic phase was concentrated and subjected to a 1:1 solution of TFA/CH 2 Cl 2 for 1 hour at room temperature. After 1 hour, the reaction was concentrated and purified by reversephase HPLC to afford the final compound. C N-Boc-(3-chlorophenyl)glycine (300 mg, 1.05 mmol, 1.0 equiv.), HOBt (161 mg, 1.05 mmol, 1.0 equiv.) and 3 (260 mg, 1.05 mmol, 1.0 equiv.) were dissolved in DMF (5 mL). EDCI (201 mg, 1.05 mmol, 1.0 equiv.) was added to the mixture and the reaction stirred overnight at room temperature. The mixture was partitioned between EtOAc and sodium carbonate, the organic phase was washed with ammonium chloride and brine. After drying over Na 2 SO 4 , the organic phase was concentrated and the crude product was purified by flash chromatography in 5% MeOH/CHCl 3 to yield 243 mg (45%) of product C. 1 I To a solution of G (72 mg, 0.21 mmol, 1.0 equiv.) in 1.5 mL dry CH 2 Cl 2 , two drops of DMF were added at room temperature. The solution was then cooled to 0°C, and oxalyl chloride (0.034 mL, 0.40 mmol, 1.9 equiv.) was added dropwise. After completion, the reaction was azeotroped with 10 mL dry toluene and dried under reduced pressure for one hour. During this time, compound H (27 mg, 0.67 mmol, 1.0 equiv.) was dissolved in 0.7 mL dry pyridine. This solution was then added to the acid chloride at 0°C. The reaction was warmed to room temp and stirred overnight under N 2 . After completion, 10 mL MeOH was added at 0°C and the mixture was stirred for an additional 30 minutes, then concentrated in vacuo. The resulting residue was dissolved in EtOAc and washed twice with each saturated K 2 CO 3 , saturated NH 4 Cl, and brine. The organic phase was concentrated in vacuo and further purified by flash chromatography in 10% MeOH/CHCl3 to afford 30.5 mg (57%) of the coupled product I. 1 
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A solution of the I (22 mg, 0.030 mmol, 1.0 equiv.) in 3 mL MeOH/H 2 O was treated with TCEP (37 mg, 0.13 mmol, 4.3 equiv.) and stirred overnight under N 2 . After completion, the reaction was concentrated in vacuo and purified by reverse-phase HPLC to afford 5.5mg (26%) of reduced azide. MS (ESI) (M + H) + = 696.8. TFA (1.5 mL) was added dropwise to a solution of the reduced azide in CH 2 Cl 2 under N 2 and stirred for 2 h at room temperature. The reaction was then azeotroped with 5 mL toluene and concentrated in vacuo to give 6.0 mg (91%) of 17. 1 
